Suppr超能文献

腺苷在骨骼肌急性缺血预处理抗梗死中的效应机制。

Effector mechanism of adenosine in acute ischemic preconditioning of skeletal muscle against infarction.

作者信息

Pang C Y, Neligan P, Zhong A, He W, Xu H, Forrest C R

机构信息

Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.

出版信息

Am J Physiol. 1997 Sep;273(3 Pt 2):R887-95. doi: 10.1152/ajpregu.1997.273.3.R887.

Abstract

We used adenosine A1 receptor agonist N6-1(phenyl-2R-isopropyl)-adenosine (PIA), A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), and ATP-sensitive K+ (KATP) channel blockers sodium 5-hydroxydecanoate (5-HD) and glibenclamide (Glib), as probes to investigate the role and mechanism of adenosine in ischemic preconditioning (IPC) of noncontractile skeletal muscle against infarction, using the pig latissimus dorsi muscle flap model. Except for Glib, all drugs were delivered to each muscle flap by 10-min local intra-arterial infusion to avoid systemic effects. Muscle flaps that were subjected to 4 h of global ischemia and 48 h of reperfusion sustained 40 +/- 2% infarction. IPC with three cycles of 10 min ischemia and reperfusion, preischemic adenosine, or PIA treatment reduced (P < 0.05) muscle infarction to 24 +/- 2, 18 +/- 2, and 24 +/- 2%, respectively. The anti-infarction effect of IPC and adenosine was blocked by DPCPX, 5-HD, and Glib (P < 0.05). Preischemic adenosine treatment also maintained higher muscle contents of phosphocreatine, ATP, and energy charge potential and lower muscle contents of dephosphorylated metabolites and lactate during ischemia and a lower muscle myeloperoxidase (MPO) activity during reperfusion compared with the control (P < 0.05). Preischemic adenosine treatment did not increase muscle content of adenosine during ischemia or reperfusion. Furthermore, adenosine given at the onset of reperfusion was not effective in attenuating muscle MPO activity or infarction. Taken together, these observations indicate that adenosine, through A1 receptors, initiates the mechanism of IPC with postreceptor involvement of KATP channels in skeletal muscle. However, adenosine is unlikely to play a key role in the effector mechanism. Presently, the cause and role of energy sparing and neutrophil inhibitory effects associated with the anti-infarction effect of preischemic adenosine treatment are unknown.

摘要

我们使用腺苷A1受体激动剂N6-1(苯基-2R-异丙基)-腺苷(PIA)、A1受体拮抗剂8-环戊基-1,3-二丙基黄嘌呤(DPCPX)以及ATP敏感性钾离子(KATP)通道阻滞剂5-羟基癸酸钠(5-HD)和格列本脲(Glib)作为探针,采用猪背阔肌皮瓣模型,研究腺苷在非收缩性骨骼肌缺血预处理(IPC)抗梗死中的作用及机制。除Glib外,所有药物均通过10分钟的局部动脉内输注给予每个肌肉皮瓣,以避免全身效应。经历4小时全心缺血和48小时再灌注的肌肉皮瓣梗死面积为40±2%。进行三个周期的10分钟缺血和再灌注的IPC、缺血前给予腺苷或PIA处理,分别将肌肉梗死面积降低(P<0.05)至24±2%、18±2%和24±2%。IPC和腺苷的抗梗死作用被DPCPX、5-HD和Glib阻断(P<0.05)。与对照组相比,缺血前给予腺苷处理在缺血期间还能维持较高的磷酸肌酸、ATP和能量电荷电位的肌肉含量,以及较低的去磷酸化代谢产物和乳酸的肌肉含量,在再灌注期间肌肉髓过氧化物酶(MPO)活性较低(P<0.05)。缺血前给予腺苷处理在缺血或再灌注期间并未增加肌肉中的腺苷含量。此外,在再灌注开始时给予腺苷对减轻肌肉MPO活性或梗死无效。综上所述,这些观察结果表明,腺苷通过A1受体启动IPC机制,且KATP通道在受体后参与其中,然而腺苷不太可能在效应机制中起关键作用。目前,与缺血前给予腺苷处理的抗梗死作用相关的能量节省和中性粒细胞抑制作用的原因及作用尚不清楚。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验